Filing Details
- Accession Number:
- 0001209191-15-086507
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-22 10:11:47
- Reporting Period:
- 2015-12-21
- Filing Date:
- 2015-12-22
- Accepted Time:
- 2015-12-22 10:11:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Transaction Summary
| Sold: | 10,400 shares | Avg. Price: $119.26 | Total Value: $1,240,312.00 |
| Number of Shares After Transactions: | 265,284 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-21 | 10,400 | $35.64 | 275,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-21 | 2,300 | $117.93 | 273,384 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-21 | 3,400 | $118.94 | 269,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-21 | 4,100 | $120.07 | 265,884 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-21 | 600 | $120.65 | 265,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-12-21 | 10,400 | $0.00 | 10,400 | $35.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 52,800 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401(k) |
| Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $117.93 (range $117.42 to $118.37).
- Open market sales reported on this line occurred at a weighted average price of $118.94 (range $118.44 to $119.34).
- Open market sales reported on this line occurred at a weighted average price of $120.07 (range $119.50 to $120.46).
- Open market sales reported on this line occurred at a weighted average price of $120.65 (range $120.56 to $120.67).
- Fully vested.
Billionaire Hedge Funds
